1. Protein acylation: mechanisms, biological functions and therapeutic targets
   Shuang Shang et al, 2022, Signal Transduction and Targeted Therapy CrossRef
2. Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
   Mathew Vithayathil et al, 2023, Hepatology International CrossRef
3. Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options
   Chunye Zhang et al, 2021, Frontiers in Endocrinology CrossRef
4. In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications
   Maria Jimenez Ramos et al, 2022, iScience CrossRef
5. The Modulatory Effects of Fatty Acids on Cancer Progression
   Annemarie J. F. Westheim et al, 2023, Biomedicines CrossRef
6. Metabolic Alterations of Hepatocellular Cancer Stem Cells
   Jan Caira David et al, 2022, Hepatobiliary Cancers: An Interdisciplinary Approach CrossRef
7. Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma
   Do-Won Jeong et al, 2023, Nature Communications CrossRef
8. Role of Immunological Cells in Hepatocellular Carcinoma Disease and Associated Pathways
   Ram Aasarey et al, 2023, ACS Pharmacology & Translational Science CrossRef
9. Protein Posttranslational Modification in Stemness Remodeling and Its Emerging Role as a Novel Therapeutic Target in Gastrointestinal Cancers
   Yifei Wang et al, 2023, International Journal of Molecular Sciences CrossRef
10. Metabolic transitions regulate global protein fatty acylation
    Manasi Talwadekar et al, 2024, Journal of Biological Chemistry CrossRef
11. Protein palmitoylation in hepatic diseases: Functional insights and therapeutic strategies
    Ying Wang et al, 2024, Journal of Advanced Research CrossRef
12. Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics
    Rhema Khairnar et al, 2023, Life Sciences CrossRef
13. Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters?
    Caecilia HC Sukowati et al, 2024, Annals of Hepatology CrossRef
14. NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models
    Jing Fang et al, 2023, Cancers CrossRef
15. Interplay Between Fatty Acids, Stearoyl-Co-A Desaturase, Mechanistic Target of Rapamycin, and Yes-Associated Protein/Transcriptional Coactivator With PDZ-Binding Motif in Promoting Hepatocellular Carcinoma
    Jihane N. Benhammou et al, 2023, Gastro Hep Advances CrossRef